SL
BMY.RT

Savior LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Savior LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-238
Closed – – 906
2020
Q4 		$0 Hold
238
– – ﹤0.01% 902
2020
Q3 		$1K Hold
238
– – ﹤0.01% 823
2020
Q2 		$1K Buy
+238
New +$859 ﹤0.01% 795

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Savior LLC's BMY.RT Position: Q1 2021 in Review

Savior LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 238 shares.

Savior LLC first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Savior LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Savior LLC sold 238 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Savior LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Savior LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Savior LLC's 13F filing for Q1 2021, filed 27 Apr 2021.